• Dr. Willmar Schwabe India Pvt. Ltd., has recently acquired Sanat Products Ltd, as a 100 percent own subsidiary of Dr. Willmar Schwabe India Pvt. Ltd

  • The company is poised to grow double digit in the next 5-10 years.

  • The company aims to expand its presence across nooks and corners of the country with 50,000 outlets over a period of next 3 – 4 years 


Dr. Willmar Schwabe India Pvt Limited has announced the acquisition of Sanat Products Limited owned by Pradip Burman, part of fast-moving consumer goods major Dabur India's Burman family and grandson of the company’s founder SK Burman, to offer a diversified range of natural products in India and worldwide. Dr. Willmar Schwabe India Pvt Limited, that has been one of the pioneers in the Homeopathy space in India plans to propel its substantial expansion in its Indian home market.

With this acquisition, the company is set to add the distribution network in the OTC segment, which augments well with the existing distribution network across India. The company's plan is to reach a good pan India presence in the next 5 years.

Dr. Willmar Schwabe India has more than 1000 employees, which is the 2nd highest number in the world in the Schwabe group of companies. The company is poised to grow in double digits in the next 5-10 years. 

Commenting on the acquisition, Mr. Ashish Kumar, Managing Director, Dr. Willmar Schwabe India Pvt Limited stated, “Sanat products are the perfect addition to the homeopathic portfolio of Schwabe India and the acquisition would allow us venturing into the OTC distribution in order to reach out to a wider range of consumers. With this acquisition along with various other strategic developments, we strive to give niche and diversified products as well as services to all our customers in India and worldwide. We are also investing significantly into new technology, and especially on the equipment for all the plants of Sanat Products Limited to make them world-class.”

“The growing interest in the natural health and lifestyle in India as well as globally, encourages us to further strengthen our focus on natural healthcare products which are set to transform people’s lifestyle for a better future. In India, our aim is to be the leading supplier in the Homeopathy market along with making a huge investment in resources to create future natural brands in the Indian OTC Market “, he further added. 

Mr. Olaf Schwabe CEO of Schwabe Group and member of the fifth generation of the Schwabe family is really enthusiastic about the acquisition and commented: “This acquisition shows our strong commitment to the Indian market and we will continue to invest in India to grow further as it is one of our important markets to focus on for future growth."

“We are looking for more similar strategic tie-ups in the future and intend to become a force to reckon with in the natural product segment in the coming 5-10 years in India.”, he further added.

Mr. Pradip Burman, Chairman SPL, which has famous brands like Sunova Bioslim, Sunova Spirulina, Sunova Curcumin, and Uplat, commented on this by saying, “With the strength of DWSI, worldwide, the immense potential of the nutraceutical OTC products of SPL can be realised. The knowledge base of SPL in extracts of medicinal plants, from the Indian traditional medicine, can also be validated for the world market”.

The Schwabe Group with its 150-year experience in high-quality pharmaceutical products offers natural solutions for different conditions. Sanat, which has a formidable presence in nutraceuticals and export of Phyto APIs to many countries of Europe and America, perfectly blends into the Schwabe’s future agenda of becoming a strong player in Natural OTC medicines in India. 

About Schwabe India

In the late 19th century, when Indian homoeopathic industry was in the dire need of quality homoeopathic medicines, Schwabe has entered into the Indian market with its flagship product Cineraria Maritima Eye Drops. After more than 120 years now, its Indian subsidiary Schwabe India is spearheading into Indian natural healthcare industry with the same commitment in maintaining high  standards  of  products. Apart from homoeopathic products, its launch of bodycare, phytopharmaceuticals and herbal products has made it a truly diversified organization operating into the natural.

The growing Indian market for Schwabe products necessitated to establish a manufacturing facility in India with the aim to provide standard quality products at affordable Indian prices. Schwabe remedies had a long tradition in India. Homoeopaths in India had used and continue to use Schwabe formulations based on their deep faith in the quality of its medicines. In fact one of the first invoices raised for India in possession, was over a century back. A state-of-the-art manufacturing plant was established in NOIDA, Uttar Pradesh, which started its operations in 1997. The plant, the only one of its kind in the country, deploys the best available technological know-how in the world today. The company imparts high grade training to its employees in India as well as at the global headquarters in Germany.

About Sanat Product Limited

Sanat Products Ltd. is an emerging innovation driven pharmaceutical company, based at the Capital of India New Delhi. Established in the year 1984, the company is engaged in the manufacturing and marketing of pharmaceutical, nutraceuticals, cosmeceuticals and herbal extracts.

The company has Research and Development (R&D), manned by competent professionals at corporate office as well as at manufacturing plants. The R&D wing of Sanat Products Limited is highly advanced and is duly recognized by the Department of Science and Technology (DST), Government of India. At the same time, our manufacturing units are well equipped with advanced extraction units, spray driers and active ingredients markers such High performance liquid chromatography (HPLC), Gas chromatography (GC) and UV spectrometers.

Under the aegis of ISO 9001, the development activities are governed by the design clause of the Total Quality System. Sanat makes it a preliminary necessity to obtain its botanicals from well-established contract farmers to ensure their quality. The products manufactured at our manufacturing units are clinically tested at our quality assurance department for the presence of pesticides, microbes and heavy metal residues to maintain International standards.

The products at Sanat are manufactured under three major divisions; Herbal Extracts division (HED), Ethical Product Division (EPD) and Consumer Product division (CPD). Herbal Extracts division (HED) is progressively engaged in the extracting and marketing of standardized Herbal Extracts of the highest quality for domestic and international customers. It is armored to meet the ever expanding needs of the pharmaceutical, cosmetic, ayurvedic and food industries. 

Ethical Product Division (EPD)/Prescription based drugs offers a diverse basket of over 25 products encompassing a wide therapeutic mix covering significant chronic and acute segments aimed at preventing, treating & curing disease. These products are spread across various segments; dental, oncology, gynecology, diabetes, cardiovascular diseases, dermatology, pain management etc. While the Consumer Product division (CPD)/Nutraceuticals range across Spirulina, Natural glow, Bioslim, and Dr. Shugar. 

Post a Comment

Previous Post Next Post